Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

March 2017 - FRMC

Department

News Connection
03/20/2017
The FDA broadened the approval of Spiriva Respimat (tiotropium bromide; Boehringer Ingelheim) inhalation spray to include children 6 and older.
The FDA broadened the approval of Spiriva Respimat (tiotropium bromide; Boehringer Ingelheim) inhalation spray to include children 6 and older.
The FDA broadened the approval...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
A study suggests that due to small sample sizes and potential conflicts of interest, manufacturer-funded studies of approved drugs may not be accurate.
A study suggests that due to small sample sizes and potential conflicts of interest, manufacturer-funded studies of approved drugs may not be accurate.
A study suggests that due to...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
Long-term opioid painkiller use appears more common among emergency department patients treated by physicians with higher opioid prescription rates.
Long-term opioid painkiller use appears more common among emergency department patients treated by physicians with higher opioid prescription rates.
Long-term opioid painkiller use...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
Nationwide health costs are expected to increase an average of 5.6% annually and will account for nearly 20% of the US economy by 2025.
Nationwide health costs are expected to increase an average of 5.6% annually and will account for nearly 20% of the US economy by 2025.
Nationwide health costs are...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
The American College of Physicians (ACP) recently issued new clinical guidelines recommending that physicians avoid prescribing pain management drugs when treating acute or subacute low back pain. 
The American College of Physicians (ACP) recently issued new clinical guidelines recommending that physicians avoid prescribing pain management drugs when treating acute or subacute low back pain. 
The American College of...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
A team of hospitalists, radiation oncologists, and interventional radiologists at the University of California at Los Angeles (UCLA) is testing an artificial intelligence prototype that acts as a virtual consultant, providing timely,...
A team of hospitalists, radiation oncologists, and interventional radiologists at the University of California at Los Angeles (UCLA) is testing an artificial intelligence prototype that acts as a virtual consultant, providing timely,...
A team of hospitalists,...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
Simple, low-cost medication reminder tools for long-term prescriptions have no significant effect on adherence rates of patients with various chronic illnesses.
Simple, low-cost medication reminder tools for long-term prescriptions have no significant effect on adherence rates of patients with various chronic illnesses.
Simple, low-cost medication...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
US hospitals could save by shifting percutaneous coronary intervention procedures to transradial, same-day discharge procedures.
US hospitals could save by shifting percutaneous coronary intervention procedures to transradial, same-day discharge procedures.
US hospitals could save by...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
Multiple sclerosis patients treated with ozanimod, a selective S1P 1 and 5 receptor modulator, were less likely to relapse than those treated with weekly Avonex.
Multiple sclerosis patients treated with ozanimod, a selective S1P 1 and 5 receptor modulator, were less likely to relapse than those treated with weekly Avonex.
Multiple sclerosis patients...
03/20/2017
First Report Managed Care
News Connection
03/20/2017
Compared with standard chemotherapy, Lynparza provided an improvement in progression-free survival of patients with HER2-negative metastatic breast cancer.
Compared with standard chemotherapy, Lynparza provided an improvement in progression-free survival of patients with HER2-negative metastatic breast cancer.
Compared with standard...
03/20/2017
First Report Managed Care

Advertisement

Advertisement

Advertisement